Los Angeles – The United States Patent and Trademark Office recently granted patent protection to Los Angeles-based ImmunoCellular Therapeutics (IMUC) for its technology in the treatment of cancer for which it holds an exclusive, worldwide license. The biotechnology company which focuses on the development of immune-based cancer therapies is calling its new patent No. 7,939,090
